Selecting Portable Ankle/Toe Brachial Pressure Index Systems for a Peripheral Arterial Disease Population Screening Programme: a Systematic Review, Clinical Evaluation Exercise, and Consensus Process

Watson, Emma; Patel, Bijendra; Katsogridakis, Emmanuel; Pepper, Coral; Messeder, S.J.; Saratzis, Athanasios; Zubair, Maria; Nicholls, J.K.; Chung, Emma; Bown, Matthew J.

doi:10.1016/j.ejvs.2022.08.008

Cited by 9 publications

(9 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, in some cases, CRP and ESR were not recommended as tools used to alter medical decision-making and the course of treatment in a patients with an indeterminate clinical suspicion of disease because of low sensitivity or specificity [ 45 ]. On the other hand, ABI is considered a useful, simple, and inexpensive tool for the diagnosis and assessment of the severity of PAOD; however, it has a wide range of sensitivity, especially in elderly individuals and patients with diabetes [ 46 , 47 ]. Second, the laboratory markers of disease severity of risk factors for cellulitis, such as the glycated hemoglobin (HBA1c) level in diabetes and renal function in chronic kidney disease, cannot be collected from the claims database.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease

et al. 2023

View full text Add to dashboard Cite

Background and objectives: The objective of this study is to elucidate peripheral occlusion artery disease (PAOD) as a risk factor for cellulitis. Materials and Methods: This is a retrospective population-based cohort study. The database is the Longitudinal Health Insurance Database, which covers two million beneficiaries from the entire population of the 2010 registry for beneficiaries in Taiwan. The PAOD group is composed of patients who were newly diagnosed with PAOD from 2001 to 2014. The non-PAOD group is composed of patients who were never diagnosed with PAOD from 2001 to 2015. All patients were followed until the onset of cellulitis, death, or until the end of 2015. Results: Finally, 29,830 patients who were newly diagnosed with PAOD were included in the PAOD group, and 29,830 patients who were never diagnosed with PAOD were included in the non-PAOD group. The incidence densities (ID) of cellulitis were 26.05 (95% CI = 25.31–26.80) patients per 1000 person-years in the PAOD group and 49.10 (95% CI = 48.04–50.19) in the non-PAOD group. The PAOD group had an increased risk of cellulitis (adjusted HR = 1.94, 95% CI = 1.87–2.01) compared to the non-PAOD group. Conclusions: Patients with PAOD were associated with a higher risk of subsequent cellulitis compared to patients without PAOD.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease

et al. 2023

View full text Add to dashboard Cite

show abstract

“…These devices were purchased as part of a larger UK screening trial [ 9 ]; “Peripheral arterial disease, High blood pressure and Aneurysm Screening Trial” (PHAST) designed to test the feasibility of adding combined PAD and hypertension screening to the UK’s existing abdominal aortic aneurysm screening programme.…”

Section: Methodsmentioning

confidence: 99%

Are portable ankle brachial pressure index measurement devices suitable for hypertension screening?

et al. 2023

Self Cite

View full text Add to dashboard Cite

Objective In a large-scale population cardiovascular screening programme, peripheral artery disease (PAD) and hypertension would ideally be rapidly assessed using a single device. The ankle-brachial pressure index (ABPI) is calculated by comparing the ankle and brachial blood pressure (BP). However, it is currently unclear whether brachial BP measurements provided by automated PAD screening systems are sufficiently accurate for simultaneous hypertension screening. Methods Two portable PAD screening devices, the MESI ABPI MD and Huntleigh’s Dopplex ABIlity, were evaluated following the European Society of Hypertension International Protocol (ESH-IP) Revision 2010 using a mercury-free sphygmomanometer as a reference device. Results On average, the MESI slightly underestimated brachial systolic blood pressure (BP) with a bias and standard deviation (SD) of -3.5 (SD: 3.3) mmHg and diastolic BP with a bias of -1.5 (SD: 2.3) mmHg. For systolic BP estimates, the Dopplex was more accurate than the MESI with a lower bias of -0.5 (SD: 4.2) mmHg but less precise. The MESI successfully fulfilled all the requirements of the ESH-IP for hypertension screening. The Dopplex device failed the ESH-IP due to the absence of DBP measurements. Conclusions The MESI device appears to be suitable for simultaneous PAD and hypertension screening as part of a preventative care programme. Huntleigh’s Dopplex ABIlity failed to pass the ESH-IP validation test. Further clinical trials are underway to assess the use of the MESI for simultaneous screening for hypertension and PAD in a population screening setting.

show abstract

“…Therefore, it is a common underlying condition that contributes to various causes of death in this population [ 3 ]. Various indexes and assessment tools can be utilized for prediction of arterial stiffness, including ankle-brachial blood pressure index (ABPI) [ 4 ], cardio-ankle vascular index (CAVI) [ 5 ] and brachial-ankle pulse wave velocity (BaPWV) [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

Association between ankle-brachial blood pressure index with all-cause and cardiovascular mortality in adults without arterial stiffness

Meng,

Jiang,

et al. 2023

BMC Geriatr

View full text Add to dashboard Cite

Purpose To explore the relationship between ankle-brachial blood pressure index (ABPI) and all-cause or cardiovascular mortality in adults without arterial stiffness. Methods A total of 6784 participants without arterial stiffness were enrolled from National Health and Nutrition Examination Survey 1999–2004. The hazard ratio (HR) and 95% confidence interval (CI) of ABPI associating with the risk of all-cause and cardiovascular mortality was calculated by Cox proportional regression models adjusted for demographic and traditional risk factors. Dose-response relationship was explored with restricted cubic spines. Results After an average follow-up of 12.1 years, 1844 all-cause deaths and 299 cardiovascular deaths occurred. Compared with the lowest ABPI quartile, the second quartile was associated with the lowest risk of all-cause mortality (HR 0.89, 95%CI 0.79–0.98; p = 0.036) and cardiovascular mortality (HR 0.75, 95%CI 0.56–0.98; p = 0.048). Besides, dose-response analysis revealed that ABPI was nonlinearly correlated to all-cause mortality (p for nonlinearity < 0.001) and linearly correlated to cardiovascular mortality (p for nonlinearity = 0.459). Conclusions The relationship between ABPI and all-cause and cardiovascular mortality followed a L-shape curve. A lower ABPI was independently associated with an increased risk of all-cause and cardiovascular mortality in adults without arterial stiffness.

show abstract

Selecting Portable Ankle/Toe Brachial Pressure Index Systems for a Peripheral Arterial Disease Population Screening Programme: a Systematic Review, Clinical Evaluation Exercise, and Consensus Process

Cited by 9 publications

References 19 publications

Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease

Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease

Are portable ankle brachial pressure index measurement devices suitable for hypertension screening?

Association between ankle-brachial blood pressure index with all-cause and cardiovascular mortality in adults without arterial stiffness

Contact Info

Product

Resources

About